3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Sarcoma
1
Gynecologic
1
Conditions
Stomach Neoplasms
4
Pain, Postoperative
4
Colorectal Neoplasms
4
Colonic Neoplasms
3
Pain
2
Agnosia
2
Postoperative Complications
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Esophageal Neoplasms
1
Emergence Delirium
1
Acute Pain
1
Abdominal Pain
1
Interventions
Acupuncture Therapy
4
Sufentanil
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Early Intervention, Educational
3
Analgesia
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
Yoga
2
Transcutaneous Electric Nerve Stimulation
2
Therapeutics
2
Surveys and Questionnaires
2
Ropivacaine
2
Palliative Care
2
Morphine
2
Interviews as Topic
2
Ethanol
2
Esketamine
2
Electroacupuncture
2
Capecitabine
2
Uncertainty
1
Transcranial Magnetic Stimulation
1
Sensitivity Training Groups
1
Saline Solution
1
Psychosocial Intervention
1
Oxycodone
1
Minocycline
1
Methods
1
Mental Status and Dementia Tests
1
Meditation
1
Massage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pain
×
Ropivacaine
×
Gastrointestinal
×
Clear all
NCT04879004
2021-05-10
EFFECT
Democritus University of Thrace
Phase NA
Unknown
40 enrolled
NCT01318161
2021-02-16
EPICOL
Örebro University, Sweden
Phase 3
Terminated
221 enrolled